Registration gives the benefit of site update e-mails and additional information from Shire on new education materials and events.
ADHD Institute Register

Guidelines are not written in stone; clinical evidence accumulates and evidence-based practice recommendations are made. International and European guidelines for attention-deficit hyperactivity disorder (ADHD) and hyperkinetic disorder (HKD) continue to be updated as new clinical data emerges. Updated recommendations are designed to improve the diagnosis and management of ADHD in clinical practice.

At Meeting of Minds X (Madrid, Spain, 17-18 April, 2018), a scientific forum initiated, organised and funded by Shire, a panel of eminent ADHD specialists (Professor Philip Asherson, Professor Patrick Bolton, Professor Tobias Banaschewski, Professor David Coghill, Professor David Daley, Dr Martin Gignac, Dr Bruno Nazar and Professor Luis Rohde) discussed clinical guidelines in detail during a discussion forum moderated by Dr Duncan Manders entitled “Clinical guidelines for the diagnosis and management of ADHD in children, adolescents and adults: updates, similarities and differences”. Please select the videos below to view a summary of the discussions.

Overview of approaches to guideline development


Similarities and differences between the guidelines


Non-pharmacological versus pharmacological treatments in guidelines


How is evidence rated when deciding how to incorporate it into a guideline?


What is the purpose of guidelines?


Are people following the guidelines?


Why is there variability in the implementation of the guidelines?


Having watched the videos on guidelines, will you be referring to them in your clinical practice more?

Filter content by:

ADHD Institue logo

You’re now being transferred to

and are leaving the ADHD Institute site

Shire has no influence or control over the content of this third party website.

Continue Cancel